Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations. [PDF]
Charpentier C, Descamps D.
europepmc +1 more source
HIV-1 Resistance to Dolutegravir in Benin: The Need to Improve and Strengthen Therapeutic Patient Education Strategies to Achieve the Third Objective 95 of UNAIDS 95-95-95 Target. [PDF]
Tchiakpe E +4 more
europepmc +1 more source
HIV-1 Genetic Diversity and Transmitted Resistance to Integrase Strand Transfer Inhibitors in Benguela, Angola. [PDF]
Godinho IS +4 more
europepmc +1 more source
Integrase inhibitor-based antiretroviral therapy drives gut microbiota remodeling and immune recovery in HIV infection. [PDF]
Karaca B +5 more
europepmc +1 more source
The LEDGIN GS-9822 inhibits HIV-2 infection and enhances HIV-2 latency. [PDF]
Bruggemans A +5 more
europepmc +1 more source
HVIface: sequence-based deep learning for decoding human-virus protein-protein interfaces. [PDF]
Gupta KK +4 more
europepmc +1 more source
Research progress on HIV-1 structural proteins and antiviral therapies. [PDF]
Wang H, Yuan J, Wang H.
europepmc +1 more source
Letter to the editor: When do rare events become expected in HIV drug resistance? [PDF]
El-Khatib Z +9 more
europepmc +1 more source
Clinical presentation and effectiveness of antiretroviral therapy in newly diagnosed people living with HIV before, during and after the COVID-19 pandemic. [PDF]
Carbone A +14 more
europepmc +1 more source
Comparative effectiveness and safety of integrase strand transfer inhibitor (INSTI)-based versus non-INSTI-based antiretroviral regimens in treatment-naïve people with HIV: A real-world retrospective cohort study. [PDF]
Ye X +10 more
europepmc +1 more source

